RATIONALE AND DESIGN FOR A PHASE 2 TRIAL OF VERINURAD PLUS ALLOPURINOL IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND HYPERURICEMIA
Publication
, Conference
Kitzman, DW; Voors, A; Mentz, R; Lewis, G; Perl, S; Myte, R; Bjorck, K; Erlandsson, F; Shah, S
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2021
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
2021
Volume
77
Issue
18
Start / End Page
597 / 597
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kitzman, D. W., Voors, A., Mentz, R., Lewis, G., Perl, S., Myte, R., … Shah, S. (2021). RATIONALE AND DESIGN FOR A PHASE 2 TRIAL OF VERINURAD PLUS ALLOPURINOL IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND HYPERURICEMIA. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 77, pp. 597–597).
Kitzman, Dalane W., Adriaan Voors, Robert Mentz, Gregory Lewis, Shira Perl, Robin Myte, Karin Bjorck, Fredrik Erlandsson, and Sanjiv Shah. “RATIONALE AND DESIGN FOR A PHASE 2 TRIAL OF VERINURAD PLUS ALLOPURINOL IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND HYPERURICEMIA.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 77:597–597, 2021.
Kitzman DW, Voors A, Mentz R, Lewis G, Perl S, Myte R, et al. RATIONALE AND DESIGN FOR A PHASE 2 TRIAL OF VERINURAD PLUS ALLOPURINOL IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND HYPERURICEMIA. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2021. p. 597–597.
Kitzman, Dalane W., et al. “RATIONALE AND DESIGN FOR A PHASE 2 TRIAL OF VERINURAD PLUS ALLOPURINOL IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND HYPERURICEMIA.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 77, no. 18, 2021, pp. 597–597.
Kitzman DW, Voors A, Mentz R, Lewis G, Perl S, Myte R, Bjorck K, Erlandsson F, Shah S. RATIONALE AND DESIGN FOR A PHASE 2 TRIAL OF VERINURAD PLUS ALLOPURINOL IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND HYPERURICEMIA. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2021. p. 597–597.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
2021
Volume
77
Issue
18
Start / End Page
597 / 597
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology